Clinical Efficacy of Desloratadine in Chronic Urticaria
- 1 January 2002
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 22 (2) , 33-41
- https://doi.org/10.2165/00044011-200222002-00004
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Antibody responses to bacteriophage φX-174 in human subjects exposed to the Antarctic winter-over model of spaceflightJournal of Allergy and Clinical Immunology, 2001
- Chronic urticariaJournal of Allergy and Clinical Immunology, 2000
- Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizineJournal of Allergy and Clinical Immunology, 1999
- Loratadine and desethoxylcarbonyl‐loratadine inhibit the immunological release of mediators from human FcɛRI+cellsClinical and Experimental Allergy, 1997
- The impact of chronic urticaria on the quality of lifeBritish Journal of Dermatology, 1997
- Dermal Mast Cell Activation by Autoantibodies Against the High Affinity IgE Receptor in Chronic UrticariaJournal of Investigative Dermatology, 1996
- Chronic UrticariaNew England Journal of Medicine, 1995
- Inhibition of IgE- and non-IgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadineJournal of Allergy and Clinical Immunology, 1994
- Autoantibodies against the High-Affinity IgE Receptor as a Cause of Histamine Release in Chronic UrticariaNew England Journal of Medicine, 1993
- Detection of circulating histamine releasing autoantibodies with functional properties of anti‐IgE in chronic urticariaClinical and Experimental Allergy, 1991